cannabis
cannabis · page 9
- Uncategorized
Canada Announces Plans to Reform Cannabis Excise Tax in 2025
Canada is set to explore a new excise tax system for cannabis businesses next year in welcome and long-awaited efforts to ‘cut red tape’.
- Uncategorized
US Cannabis Industry Growth Slows to a Crawl Amid Price Compression and Delayed Federal Reform
US cannabis industry revenues are set to grow just 3.2% in 2025, as price compression, difficult economic dynamics and an increasingly complex political landscape put the brakes on the sector.
- Uncategorized
Hunter Biden Pardon Sparks Intensified Calls for Federal Cannabis Clemency, With Suggestions More Could Be On the Way
Joe Biden’s controversial pardon of his son Hunter Biden has seen pressure build on the outgoing US president to make good on his promises of widespread clemency for low-level cannabis convictions.
- Uncategorized
Cannabis Rescheduling Hearing Set to Begin on January 21 for 6 Weeks, As Frustrations Over Process Continue to Build
The Drug Enforcement Administration (DEA) has scheduled an official date for the highly anticipated public hearing on cannabis rescheduling, starting with a presentation from the government just a day after President Elect Donald Trump is sworn in.
- Uncategorized
DEA Cannabis Rescheduling Hearing Takes Landmark First Step
The first step in the US’s landmark efforts to reschedule cannabis officially took place yesterday, setting the stage for what is set to be a lively and heated process.
- Uncategorized
Trump’s Cabinet Picks Leave Cannabis Reform in Limbo: A Mixed Bag of Allies and Opponents
Following the short-lived candidacy of Matt Gaetz for US Attorney General in President elect Donald Trumps new cabinet, the outlooks for cannabis reform under the incoming government is now looking much more complex.
- Uncategorized
Cannabis Trade Dispute Between Canada and Israel Escalates Amid Allegations of Flawed Tariff Methodology
The Canadian Cannabis Council (C3) has pushed back on Israel’s continued claims of ‘product dumping’, in the latest escalation of a contentious trade dispute.
- Uncategorized
FDA Approves Clinical Trial Into Cannabis as a Treatment for PTSD Following a 3-Year Block
The US Food and Drug Administration (FDA) has finally approved a Phase 2 clinical trial into cannabis in treatment of post-traumatic stress disorder (PTSD), three years after being put on hold.
- Uncategorized
Weather Boosts Yields, Quality, and Optimism for California’s Sun-Grown Cannabis Market
California cannabis farmers growing their plants under the sun said the weather cooperated during the 2024 growing season.
- Uncategorized
GOP in Charge: Can Republicans Deliver on Cannabis Reform?
Is Republican control of the U.S. government better for marijuana reform than a Democrat-led administration, and have statewide adult-use cannabis legalization efforts simply maxed out?
- Uncategorized
New York’s Cannabis Market Could Top Sales of $3.3bn by 2027
New York’s legal cannabis market could see annual sales top $6bn within two years, according to new analysis from Whitney Economics.
- Opinion
Could Cannabis Capital Markets Thrive Next Year?
The marijuana capital markets have experienced a whirlwind over the past few years – and this year’s elections around the nation show little sign of affecting the capital markets no matter who comes out on top.
